Hongxia Zhu
- Cancer Research top 2%
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 7
- Molecular Biology top 5%
- Cancer-related gene regulation 12
- Wnt/β-catenin signaling in development and cancer 11
- Kruppel-like factors research 10
- Circular RNAs in diseases 9
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
- Cancer-related Molecular Pathways 10
- Cell Biology top 5%
- Immunology top 10%
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (6 papers)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Hongxia Zhu
106 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 756
- Molecular Biology 1.9k
- Oncology 655
- Cell Biology 315
- Immunology 348
Countries citing papers authored by Hongxia Zhu
This map shows the geographic impact of Hongxia Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Zhu more than expected).
Fields of papers citing papers by Hongxia Zhu
This network shows the impact of papers produced by Hongxia Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Zhu. The network helps show where Hongxia Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongxia Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 17 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 18 | |
| 10 | Efficacy And Safety Of Apatinib Treatment In Platinum-Resistant Recurrent Epithelial Ovarian Cancer: A Real World Study | 2019 | 2 |
| 11 | 2019 | 43 | |
| 12 | 2017 | 26 | |
| 13 | 2017 | 43 | |
| 14 | 2013 | 26 | |
| 15 | 2012 | 33 | |
| 16 | 2012 | 37 | |
| 17 | 2010 | 32 | |
| 18 | 2006 | 39 | |
| 19 | 2006 | 43 | |
| 20 | [Survivin mutants reverse the malignancy of HeLa cells]. | 2003 | 2 |
About Hongxia Zhu
Hongxia Zhu is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 110 papers that have together received 2.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer-related gene regulation (12 papers), Wnt/β-catenin signaling in development and cancer (11 papers), Cancer-related Molecular Pathways (10 papers), Kruppel-like factors research (10 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (756 citations), Molecular Biology (1.9k citations) and Oncology (655 citations). Hongxia Zhu has collaborated with scholars based in China, United States and India. Frequent co-authors include Ningzhi Xu, Shufang Liang, Lanping Quan, Jinfeng Bai, Yihua Wang, Xixi Wang, Yanfang Yang, Cuiqi Zhou, Mei Liu and Chenfei Hu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.